What this study is
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
What's being tested
- biologic sample preservation procedure
Intervention · OTHER
All samples collected during routine clinical care.
- cytology specimen collection procedure
Intervention · OTHER
All Samples collected during routine clinical care.
Study details
- Official title
- Tissue Procurement For Hematolymphoid Conditions
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Conditions
- Chronic Myeloproliferative Disorders · Leukemia · Lymphoma · Lymphoproliferative Disorder · Multiple Myeloma and Plasma Cell Neoplasm · Myelodysplastic Syndromes · Myelodysplastic/Myeloproliferative Neoplasms · Nonmalignant Neoplasm
- Enrolling
- 15,000 people
- Starts
- 2009-07
- Est. completion
- 2040-07
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 120 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- DISEASE CHARACTERISTICS:
- Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following:; Acute myeloid leukemia; Acute lymphoblastic leukemia; Chronic myelogenous leukemia; Chronic lymphoid leukemia; Non-Hodgkin lymphoma; Hodgkin lymphoma; Myelodysplastic syndromes; Myeloproliferative disorders; Multiple myeloma; Waldenstrom macroglobulinemia; Aplastic anemia; Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage
- Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital PATIENT CHARACTERISTICS:; Not specified PRIOR CONCURRENT THERAPY:; Not specified
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openLineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Tissue Procurement Facility · Contact919-966-2620
Recruiting
Study team
Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID LCCC 0824
Principal investigator
Paul Armistead, MD
UNC Lineberger Comprehensive Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.